{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:19:02Z","timestamp":1788347942970,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.tracli.2021.08.006","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T15:13:45Z","timestamp":1629213225000},"page":"407-413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Post-donation information management"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9951-6119","authenticated-orcid":false,"given":"Tomislav","family":"Vuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Garraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantina","family":"Politis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2021.08.006_bib0300","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/187152611794407746","article-title":"Approaches to minimize infection risk in blood banking and transfusion practice","volume":"11","author":"Lindholm","year":"2011","journal-title":"Infect Disord Drug Targets"},{"key":"10.1016\/j.tracli.2021.08.006_bib0305","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.tracli.2019.07.004","article-title":"Post-donation information management\u2013contribution to the safety of transfusion treatment","volume":"26","author":"Vuk","year":"2019","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2021.08.006_bib0310","first-page":"328","article-title":"\u00c9volution des informations post don en Normandie","volume":"15","author":"Girard","year":"2008","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2021.08.006_bib0315","first-page":"260","article-title":"Les informations post don, un enjeu de la s\u00e9curit\u00e9 sanitaire: analyse de 26 943 cas. Abstract S09-3 in XXIV Congr\u00e8s national de la SFTS","volume":"16","author":"Simonet","year":"2009","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2021.08.006_bib0320","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.tracli.2010.09.161","article-title":"La gestion des informations post-don\u00a0: un \u00e9l\u00e9ment fondamental de la s\u00e9curit\u00e9 transfusionnelle","volume":"17","author":"Herv\u00e9","year":"2010","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2021.08.006_bib0325","series-title":"Guide to the Preparation, Use and Quality Assurance of Blood Components","author":"EDQM (European Directorate for the Quality of Medicines & Health Care of the Council of Europe)","year":"2020"},{"key":"10.1016\/j.tracli.2021.08.006_bib0330","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.tmrv.2014.09.002","article-title":"Postdonation information and blood component retrievals: realigning blood center and hospital actions based on risk assessment","volume":"28","author":"Eder","year":"2014","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tracli.2021.08.006_bib0335","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.1537-2995.2010.03043.x","article-title":"NHLBI Retrovirus Epidemiology Donor Study-II. Characteristics of post donation information donors and comparison with appropriately deferred donors","volume":"51","author":"Wilkinson","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.006_bib0340","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.tmrv.2012.11.001","article-title":"Blood component recalls and market withdrawals: frequency, reasons, and management in the United States","volume":"27","author":"Ramsey","year":"2013","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tracli.2021.08.006_bib0345","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1537-2995.2003.00275.x","article-title":"An objective structured clinical examination to evaluate health historian competencies","volume":"43","author":"Lee","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.006_bib0350","unstructured":"Food and Drug Administration (FDA). Biological product and HCT\/P deviation reports\u2014annual summary for fiscal year 2017. Available at: https:\/\/www.fda.gov\/media\/114257\/download. Accessed: June 17, 2021."},{"key":"10.1016\/j.tracli.2021.08.006_bib0355","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.1997.03540360035027","article-title":"Estimates of infectious disease risk factors in U.S. blood donors. Retrovirus Epidemiology Donor Study","volume":"277","author":"Williams","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.tracli.2021.08.006_bib0360","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1046\/j.1537-2995.2001.41060736.x","article-title":"for the Retrovirus Epidemiology Donor Study. Repeat whole-blood and plateletpheresis donors: unreported deferrable risks, reactive screening tests, and response to incentive programs","volume":"41","author":"Glynn","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.006_bib0365","first-page":"35S","article-title":"Evaluation of donors who give primarily for HIV testing","volume":"41","author":"Schreiber","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.006_bib0370","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-3148.2009.00969.x","article-title":"Understanding non-disclosure of deferrable risk: a study of blood donors with a history of intravenous drug use","volume":"20","author":"O\u2019Brien","year":"2010","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2021.08.006_bib0375","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/j.1537-2995.2011.03078.x","article-title":"Donor understanding and attitudes about current and potential deferral criteria for high-risk sexual behavior","volume":"51","author":"Goldman","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.006_bib0380","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1111\/trf.12144","article-title":"Trends in transfusion-transmissible infections among Australian blood donors from 2005 to 2010","volume":"53","author":"Lucky","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.006_bib0385","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/trf.12554","article-title":"Understanding noncompliance with selective donor deferral criteria for high-risk behaviors in Australian blood donors","volume":"54","author":"Lucky","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.006_bib0390","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1182\/bloodadvances.2019001024","article-title":"A cross-sectional study of prevalence, distribution, cause, and impact of blood product recalls in the United States","volume":"4","author":"Alqemlas","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.tracli.2021.08.006_bib0395","unstructured":"EC. Commission staff working document on the application of Directive 2002\/98\/EC on\u00a0setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001\/83\/EC. EC, Brussels, 21.4.2016 SWD (2016) 129 final."},{"key":"10.1016\/j.tracli.2021.08.006_bib0400","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1046\/j.1537-2995.2003.00473.x","article-title":"Retrovirus Epidemiology Donor Study. Do blood donors read and understand screening educational materials?","volume":"43","author":"Rugege-Hakiza","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.006_bib0405","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1537-2995.2011.03430.x","article-title":"for the NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II). Donors\u2019 perspectives on their postdonation information (PDI) event: a qualitative interview study of PDI donors","volume":"52","author":"Wilkinson","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.006_bib0410","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1111\/j.1537-2995.2006.01048.x","article-title":"The Canadian donor health assessment questionnaire: can it be improved?","volume":"46","author":"Goldman","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.006_bib0415","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1126\/science.3563494","article-title":"Answering autobiographical questions; the impact of memory and inference on surveys","volume":"236","author":"Bradburn","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.tracli.2021.08.006_bib0420","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1423-0410.2007.01034.x","article-title":"Donor's understanding of the definition of sex as applied to predonation screening questions","volume":"94","author":"O\u2019Brien","year":"2008","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2021.08.006_bib0425","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1046\/j.1537-2995.2001.41111341.x","article-title":"Retrovirus Epidemiology Donor Study. Knowledge of HIV\/AIDS transmission and screening in United States blood donors","volume":"41","author":"Sharma","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.006_bib0430","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.tmrv.2007.03.002","article-title":"The Canadian blood donor health assessment questionnaire: lessons from history, application of cognitive science principles, and recommendations for change","volume":"21","author":"O\u2019Brien","year":"2007","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tracli.2021.08.006_bib0435","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-3148.2007.00797.x","article-title":"Factors that motivate and hinder blood donation in Greece","volume":"17","author":"Marantidou","year":"2007","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2021.08.006_bib0440","series-title":"Towards 100% voluntary blood donation: a global framework for action","author":"World Health Organization & International Federation of Red Cross and Red Crescent Societies","year":"2010"},{"key":"10.1016\/j.tracli.2021.08.006_bib0445","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.biologicals.2009.10.013","article-title":"Should we neglect or nurture replacement blood donors in sub - Saharan Africa?","volume":"38","author":"Bates","year":"2010","journal-title":"Biologicals"},{"key":"10.1016\/j.tracli.2021.08.006_bib0450","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/vox.12298","article-title":"Donor attention to reading materials","volume":"109","author":"O\u2019Brien","year":"2015","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2021.08.006_bib0455","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/vox.12179","article-title":"Sexual risk behaviour and donor deferral in Europe","volume":"107","author":"Offergeld","year":"2014","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2021.08.006_bib0460","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.tmrv.2007.03.001","article-title":"A question of clarity: redesigning the American Association of Blood Banks blood donor history questionnaire\u2014a chronology and model for donor screening","volume":"21","author":"Fridey","year":"2007","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tracli.2021.08.006_bib0465","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1046\/j.1537-2995.2000.40111407.x","article-title":"Validation of selected donor-screening questions: structure, content and comprehension","volume":"40","author":"Orton","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.006_bib0470","series-title":"Resolution CM\/Res (2013)3 on sexual behaviours of blood donors that have an impact on transfusion safety. Adopted by the Committee of Ministers on 27 March 2013 at the 1166th meeting of the Ministers\u2019 Deputies","year":"2013"},{"key":"10.1016\/j.tracli.2021.08.006_bib0475","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1537-2995.2004.00623.x","article-title":"Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti-HCV","volume":"44","author":"Orton","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.006_bib0480","unstructured":"Resolution CM\/Res (2008)5 on donor responsibility and on limitation to donation of blood and blood components. Available at:\u00a0https:\/\/ekea.gr\/wp-content\/uploads\/Resolution_CMRes20085_on_donor_responsibility_and_on_limitation_to_donation_of_blood_and_blood_components.pdf (Accessed: April 19, 2021)."},{"key":"10.1016\/j.tracli.2021.08.006_bib0485","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/trf.12349","article-title":"Cost-effectiveness of questionnaires in preventing transfusion-transmitted infections","volume":"54","author":"de\u00a0Kort","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.006_bib0490","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pec.2005.05.004","article-title":"The role of pictures in improving health communication: a review of research on attention, comprehension, recall, and adherence","volume":"61","author":"Houts","year":"2006","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.tracli.2021.08.006_bib0495","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.1537-2995.1989.29489242806.x","article-title":"Impact of explicit questions about high-risk activities on donor attitudes and donor deferral patterns. Results in two community blood centers","volume":"29","author":"Silvergleid","year":"1989","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.006_bib0500","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.transci.2009.07.006","article-title":"Quality assurance of the donor questionnaire and donor interview: a three year experience with an electronic donor questionnaire","volume":"41","author":"Flesland","year":"2009","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2021.08.006_bib0505","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/voxs.12219","article-title":"Can we make the predonation screening process more effective?","volume":"11","author":"Norda","year":"2016","journal-title":"ISBT Science Series"},{"key":"10.1016\/j.tracli.2021.08.006_bib0510","first-page":"341","article-title":"Sources of error in a survey on sexual behavior","volume":"13","author":"Tourangeau","year":"1997","journal-title":"J Off Stat"},{"key":"10.1016\/j.tracli.2021.08.006_bib0515","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0887-7963(98)80004-7","article-title":"Donor selection procedures: is it possible to improve them?","volume":"12","author":"Kleinman","year":"1998","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tracli.2021.08.006_bib0520","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1111\/j.1537-2995.2007.01329.x","article-title":"The donor health assessment questionnaire: potential for format change and computer-assisted self-interviews to improve donor attention","volume":"47","author":"Goldman","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.006_bib0525","series-title":"Annual epidemiological surveillance report\u2013Malaria in Greece","author":"NPHO","year":"2020"},{"key":"10.1016\/j.tracli.2021.08.006_bib0530","series-title":"Annual epidemiological report for West Nile virus human infection, Greece","author":"NPHO","year":"2020"},{"key":"10.1016\/j.tracli.2021.08.006_bib0535","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1537-2995.1998.38498257373.x","article-title":"Demographic characteristics, unreported risk behaviors, and the prevalence and incidence of viral infections; a comparison of apheresis and whole blood donors. The Retrovirus Epidemiology Donor Study","volume":"38","author":"Glynn","year":"1998","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.006_bib0540","first-page":"93","article-title":"Viral metagenomics in blood donations with post-donation illness reports from Brazil","volume":"19","author":"Dos Santos Bezerra","year":"2021","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tracli.2021.08.006_bib0545","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.tracli.2015.12.002","article-title":"Viral metagenomics and blood safety","volume":"23","author":"Sauvage","year":"2016","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2021.08.006_bib0550","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.tracli.2017.06.018","article-title":"The potential of viral metagenomics in blood transfusion safety","volume":"24","author":"Sauvage","year":"2017","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2021.08.006_bib0555","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tmrv.2003.10.005","article-title":"Managing recalls and withdrawals of blood components","volume":"18","author":"Ramsey","year":"2004","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tracli.2021.08.006_bib0560","series-title":"Recommendations for the notification of recipients of a blood component recall","year":"2018"},{"key":"10.1016\/j.tracli.2021.08.006_bib0565","unstructured":"Australian Red Cross. Recommendations for the Notification of Recipients of a Recalled Blood Component. GEN-00213, Version 2, Effective date: 18\/11\/2019."},{"key":"10.1016\/j.tracli.2021.08.006_bib0570","unstructured":"Commission Directive 2004\/33\/EC of 22 March 2004 implementing Directive 2002\/98\/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components. OJ, L91, 30\/3\/2004, p.\u00a029."},{"key":"10.1016\/j.tracli.2021.08.006_bib0575","doi-asserted-by":"crossref","DOI":"10.1111\/j.1537-2995.2009.02279.x","article-title":"Emerging infectious disease agents and their potential threat to transfusion safety","volume":"49","author":"Stramer","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.006_bib0580","first-page":"1","article-title":"West Nile Virus (WNV) outbreak in Greece and blood safety measures","volume":"101","author":"Politis","year":"2011","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2021.08.006_bib0585","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tracli.2020.10.007","article-title":"Post-donation information and haemovigilance reporting for COVID-19 in Greece: Information supporting the absence of SARS-CoV-2 possible transmission through blood components","volume":"28","author":"Politis","year":"2021","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2021.08.006_bib0590","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.tracli.2014.08.134","article-title":"L\u2019information post-don, le quatri\u00e8me sous-processus de l\u2019h\u00e9movigilance","volume":"21","author":"Py","year":"2014","journal-title":"Transfus Clin Biol"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782021001208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782021001208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:38:32Z","timestamp":1761129512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782021001208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1246782021001208"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2021.08.006","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-donation information management","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2021.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}